Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) announced that its Board of Directors has approved the repurchase of up to an aggregate of $2,000,000 of its Class A common stock out of the $10,000,000 authorized by the Board on December 9, 2008. At that time, the Board authorized a stock repurchase program in which the Company may use up to $10,000,000 to purchase shares of its Class A common stock. The repurchases will be made from time to time on the open market at the prevailing market prices or in negotiated transactions off the market. The repurchase program is expected to continue through to the third quarter of 2012 unless extended or shortened by the Board of Directors.

Read more at: http://crwewallstreet.com/?p=21272